Essential role of tumor necrosis factor α (TNF-α) in tumor promotion as revealed by TNF-α-deficient mice

Cancer Research

Volumn 59, Issue 18, 1999, Pages 4516-4518

  Suganuma, Masami ^a   Okabe, Sachiko ^a   Marino, Michael W ^b   Sakai, Ayako ^c   Sueoka, Eisaburo ^a   Fujiki, Hirota ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DIMETHYLBENZ[A]ANTHRACENE; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; OKADAIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; GENE EXPRESSION; HUMAN; MOUSE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SKIN; TUMOR GROWTH;

3T3 CELLS; 9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CELL DIVISION; CELL LINE, TRANSFORMED; FEMALE; GENES, RAS; INTERLEUKIN-1; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; OKADAIC ACID; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033568358     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Fujiki, H., Hecker, E., Moore, R. E., Sugimura, T., and Weinstein, I. B. (eds.). Cellular Interactions by Environmental Tumor Promoters. Tokyo: Japan Scientific Societies Press, 1983.
2. Komori, A., Yatsunami, J., Suganuma, M., Okabe, S., Abe, S., Sakai, A., Sasaki, K., and Fujiki, H. Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res., 53: 1982-1985, 1993.
3. Fujiki, H., and Suganuma, M. Tumor necrosis factor-α, new tumor promoter, engendered by biochemical studies of okadaic acid. J. Biochem. (Tokyo), 115: 1-5, 1994.
4. Sueoka, N., Sueoka, E., Miyazaki, Y., Okabe, S., Kurosumi, M., Takayama, S., and Fujiki, H. Molecular pathogenesis of interstitial pneumonitis with TNF-α transgenic mice. Cytokine, 10: 124-131, 1998.
5. Marino, M. W., Dunn, A., Grail, D., Inglese, M., Noguchi, Y., Richards, E., Jungbluth, A., Wada, H., Moore, M., Williamson, B., Basu, S., and Old, L. J. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA, 94: 8093-8098, 1997.
6. Doi, T. S., Marino, M. W., Takahashi, T., Yoshida, T., Sakakura, T., Old, L. J., and Obata, Y. Absence of tumor necrosis factor rescues Rel-A-deficient mice from embryonic lethality. Proc. Natl. Acad. Sci. USA, 96: 2994-2999, 1999.
7. Fujiki, H., and Suganuma, M. Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds. Adv. Cancer Res., 61: 143-194, 1993.
8. Suganuma, M., Fujiki, H., Suguri, H., Yoshizawa, S., Hirota, M., Nakayasu, M., Ojika, M., Wakamatsu, K., Yamada, K., and Sugimura, T. Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter. Proc. Natl. Acad. Sci. USA, 85: 1768-1771, 1988.
9. Sasaki, K., Mizusawa, H., Ishidate, M., and Tanaka, N. Transformation of ras transformed BALB 3T3 clone (Bhas 42) by promoters: application for screening and specificity of promoters. Toxicol. In Vitro, 4: 657-659, 1990.
10. Kopf, M., Brombacher, F., Kohler, G., Kienzle, G., Widmann, K. H., Lefrang, K., Humborg, C., Ledermann, B., and Solbach, W. IL-4-deficient Balb/c mice resist infection with Leishmania major. J. Exp. Med., 184: 1127-1136, 1996.
11. Fujiki, H., and Sugimura, T. New classes of tumor promoters: teleocidin, aplysiatoxin, and palytoxin. Adv. Cancer Res., 49: 223-264, 1987.
12. Neurath, M. F., Becker, C., and Barbulescu, K. Role of NF-κB in immune and inflammatory responses in the gut. Gut, 46: 856-860, 1998.
13. Lee, W. Y., Fischer, S. M., Butler, A. P., and Locniskar, M. F. Modulation of interleukin-1a mRNA expression in mouse epidermis by tumor promoters and antagonists. Mol. Carcinog., 7: 26-35, 1993.
14. Oberyszyn, T. M., Sabourin, C. L., Bijur, G. N., Oberyszyn, A. S., Boros, L. G., and Robertson, F. M. Interleukin-1α gene expression and localization of interleukin-1α protein during tumor promotion. Mol. Carcinog., 7: 238-248, 1993.
15. Fujiki, H., Suganuma, M., Okabe, S., Sueoka, E., and Iida, N. Transforming activity of TNF-α and analysis of its transformant. Jpn. J. Cancer Res., 89 (Suppl.): 604, 1998.
16. Budunova, I. V., Gamel, D. N., Vaden, V. R., and Slaga, T. J. Constitutive activation of NF-κB factors in mouse skin tumors as a result of altered expression of NF-κB/IκB proteins. Proc. Am. Assoc. Cancer Res., 40: 98, 1999.
17. Fujiki, H., Sueoka, E., Komori, A., and Suganuma, M. Tumor promotion and TNF-α gene expression by the okadaic acid class tumor promoters. Environ. Carcino & Ecotox. Revs., C15: 1-40, 1997.
18. Suganuma, M., Okabe, S., Sueoka, E., Iida, N., Komori, A., Kim, S. J., and Fujiki, H. A new process of cancer prevention mediated through inhibition of tumor necrosis factor α expression. Cancer Res., 56: 3711-3715, 1996.
19. Gutman, M., Inbar, M., Lev-Shlush, D., Abu-Abid, S., Mozes, M., Chaitchik, S., Meller, I., and Klausner, J. M. High dose tumor necrosis factor-α and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation. Cancer (Phila.), 79: 1129-1137, 1997.